Markets
2023 WSJ's Future Of Everything Festival
NEW YORK, NEW YORK - MAY 02: Nick Timiraos, Richard Clarida, and Michelle Meyer attend 2023 WSJ's Future Of Everything Festiva (Photo by Joy Malone/Getty Images)
50 you hot

The market is listening to the media

The odds of a 50 basis point rate cut at this week's Fed meeting continue to creep higher.

Luke Kawa

The pen is mightier than the trading floor’d.

Articles published by prominent journalists who cover the Federal Reserve last week, most notably the Wall Street Journal’s Nick Timiraos, are continuing to prompt a significant re-evaluation of how much the US central bank will cut interest rates this week.

After a so-so monthly increase in the core consumer price index for August, the odds of a 50 basis point rate reduction this week went below 15%. On Monday morning, the likelihood of a cut that large is approaching 70%.

“The Committee is certainly cognizant of the market’s expectations and in the event that a 50 basis point cut is more than 80% priced in, such a move might be the Fed’s decision to prevent a sharp selloff in risk assets,” writes BMO Capital Markets head of US rates strategy Ian Lyngen.

This Deutsche Bank chart from a note published Friday shows just how unusual it is for a Federal Reserve meeting to have this much uncertainty this close to the event. Except now on Monday morning, the state of affairs is flipped – it would be more surprising if the central bank cut by only 25 basis points.

DBmarketsurprise
Source: X via @jeuasommenulle

The central bank using a high-profile media contact (often at the Wall Street Journal) to guide the market in a certain direction during the “blackout period” in which US monetary policymakers are unable to speak to the public would not be a new phenomenon. The June 13, 2022 article from Nick Timiraos (“Fed likely to consider 0.75-percentage-point rate rise this week”) stands out. Market pricing implied traders thought there was less than a 30% chance of that outcome before that was published; by the end of the next trading day, the odds of a 75 basis point hike were priced at 90%. 

In a separate report, Deutsche Bank economists even turned to their proprietary artificial intelligence tool to analyze the language used in last week’s article compared to Timiraos’ pointed message from June 2022. 

The AI results suggested that the June 2022 article’s tone was “urgent and decisive,” suggesting high conviction in the result being prophesied. The more recent post, on the other hand, was “balanced and analytical” with “moderate to low” conviction. 

“While there were echoes of that earlier period in this week’s reporting, we also felt that the level of conviction was greater in the June 2022 articles,” write Deutsche Bank economists led by Matthew Luzzetti. “While we know AI results can be inaccurate or subject to criticism, the sentiment analysis from DB’s tool matches our own perception of the conviction level of each article.”

Of course, while media missives appear to be playing the dominant role, there may be more to the massive repricing. After the producer price index and import data that were released following August’s CPI report, inflation forecasters generally expect that the Federal Reserve’s preferred gauge of inflation (released near the end of the month) will have gone up at a very modest pace last month. 

More Markets

See all Markets
markets

FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation

The Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 compounding, a day after Hims & Hers announced that it would sell copies ofNovo Nordisk’sWegovy pill.

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

Airlines rise, continuing their volatile 2026, as US-Iran talks may foreshadow some oil supply relief

Airline stocks are surging on Friday, as the market appears to be pricing in some medium-term oil pricing relief following talks between the US and Iran. Iranian officials referred to the meeting as “a good beginning.”

Shares of budget carriers, which have tighter margins and are more sensitive to fluctuations in fuel costs, are leading the surge. Frontier Airlines and Allegiant up more than 13%, while major airlines like United Airlines, American Airlines, and Delta Air Lines are also up at least 6%. JetBlue and Alaska Air are similarly up about 6%.

The market more broadly is rebounding on Friday, with the S&P 500 up 1.6% and bitcoin recovering some of this week’s losses.

Airlines have been volatile to start 2026 amid geopolitical tensions, varying annual forecasts, and the impact of winter storms.

markets
Luke Kawa

The AI supply chain is soaring thanks to Amazon’s capex budget

If tech companies are going to spend way more than expected on capex, well, that means other companies are poised to benefit from that massive spending spree.

Amazon’s plan for $200 billion in business investment this year was the exclamation point to end a reporting period that saw every Magnificent 7 hyperscaler that provides guidance offer a 2026 capex budget well above what Wall Street had anticipated.

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

markets

For memory chips, the “parabolic price hike” is continuing to ramp higher

The remarkable run-up in prices for memory chips continued into early February, analysts at Bernstein Research say, driven largely by data center demand from hyperscalers and cloud service providers (CSP).

Prices for NAND flash memory wafers — a type of memory used in devices, as it retains data even when powered down — soared 35% between the end of 2025 and February 2.

Spot prices for DRAM — ubiquitous short-term data storage chips — jumped about 28% in that period. But that massively understates the remarkable shift in pricing for what were long seen as commodity tech hardware inputs. DRAM prices are more than 2,000% over the last year, while NAND prices are up more than 600% in that period.

The ongoing momentum provides still more support for memory chip plays like Micron and Sandisk, which have been big market winners in recent months.

In a note published earlier this week, Bernstein Research analysts wrote:

“The parabolic price hike continued in Jan. Indicated price increase for 1QCY26 is much stronger than we expected and we hence see upside to our near term memory pricing projection. Unrelenting CSP demand remained the main driver. PC and Mobile demand hasn’t been destroyed yet because of lean inventory & pull-forward purchase. Going forward price hike is expected to continue but likely at a slower rate, as PC and Mobile demand should contract meaningfully this year. Price however may stay elevated throughout this year, supported by CSP demand.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.